Improving the acceptability of the atrial defibrillator for the treatment of persistent atrial fibrillation: The atrial defibrillator sedation assessment study (ADSAS)

International Journal of Cardiology

Volumn 96, Issue 2, 2004, Pages 141-145

  Mitchell, Andrew R J ^a   Spurrell, Philip A R ^a   Gerritse, Bart E W ^b   Sulke, Neil ^a  

^a EASTBOURNE DISTRICT GENERAL HOSPITAL   (United Kingdom)

^b MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

Author keywords

Analgesia; Atrial defibrillator; Atrial fibrillation; Sedation

Indexed keywords

ANALGESIC AGENT; DEXTROMORAMIDE; LORAZEPAM; MIDAZOLAM; MORPHINE SULFATE;

ADULT; AGED; ANXIETY; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; CONFIDENCE INTERVAL; DEFIBRILLATION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; MALE; PAIN; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS; ATRIAL FIBRILLATION; CHRONIC DISEASE; CONFIDENCE INTERVALS; CONSCIOUS SEDATION; CROSS-OVER STUDIES; CYCLIZINE; DEFIBRILLATORS, IMPLANTABLE; DEXTROMORAMIDE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LORAZEPAM; MALE; MIDAZOLAM; MIDDLE AGED; MORPHINE; PAIN MEASUREMENT; PATIENT ACCEPTANCE OF HEALTH CARE; PREMEDICATION; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 3242775496     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.04.060     Document Type: Article

References (25)

1. Daoud E.G., Timmermans C., Fellows C., et al. Initial clinical experience with ambulatory use of an implantable atrial defibrillator for conversion of atrial fibrillation. Metrix Investigators. Circulation. 102:2000;1407-1413
2. Gold M.R., Sulke N., Schwartzman D., et al. Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias. J. Cardiovasc. Electrophysiol. 12:2001;1247-1253
3. Friedman P.A., Dijkman B., Warman E.N., et al. Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation. 104:2001;1023-1028
4. Seidl K., Hauer B., Kirca M., et al. Importance of preimplantation procedures in candidates for an implantable atrial defibrillator. J. Cardiovasc. Electrophysiol. 9:1998;S127-S131
5. Jung W., Wolpert C., Esmailzadeh B., et al. Specific considerations with the automatic implantable atrial defibrillator. J. Cardiovasc. Electrophysiol. 9:1998;S193-S201
6. Boriani G., Biffi M., Bronzetti G., et al. Efficacy and tolerability in fully conscious patients of transvenous low-energy internal atrial cardioversion for atrial fibrillation. Am. J. Cardiol. 81:1998;241-244
7. Haffajee C.I., Chaudhry G.M., Casavant D., et al. Efficacy and tolerability of automatic night-time atrial fibrillation shocks in patients with permanent internal atrial defibrillators. Am. J. Cardiol. 89:2002;875-878
8. Timmermans C., Rodriguez L.M., Ayers G.M., et al. Effect of butorphanol tartrate on shock-related discomfort during internal atrial defibrillation. Circulation. 99:1999;1837-1842
9. Mitchell A.R., Spurrell P.A., Boodhoo L.A., et al. Psychosocial aspects of patient-activated atrial defibrillation. J. Cardiovasc. Electrophysiol. 14(8):2003;812-816
10. Lok N.S., Lau C.P., Tse H.F., et al. Clinical shock tolerability and effect of different right atrial electrode locations on efficacy of low energy human transvenous atrial defibrillation using an implantable lead system. J. Am. Coll. Cardiol. 30:1997;1324-1330
11. Sears S.F. Jr., Conti J.B. Quality of life and psychological functioning of ICD patients. Heart. 87:2002;488-493
12. Ujhelyi M.R., Sears S.F. Jr., Burns J.L., et al. Characterization of atrial shock pain from implantable atrial defibrillator: patient activated vs. automatic night-time atrial shocks. Pacing Clin. Electrophysiol. 24:2002;712
13. Raybould D., Bradshaw E.G. Premedication for day case surgery. A study of oral midazolam. Anaesthesia. 42:1987;591-595
14. Raipancholia R., Sentinella L., Lynch M. Role of conscious sedation for external cardioversion. Heart. 86:2001;571A-572
15. Pugh P.J., Spurrell P., Kamalvand K., et al. Sedation by physician with diazepam for DC cardioversion of atrial arrhythmias. Heart. 86:2001;572-573
16. Nordt S.P., Clark R.F. Midazolam: a review of therapeutic uses and toxicity. J. Emerg. Med. 15:1997;357-365
17. Kowey P.R. The calamity of cardioversion of conscious patients. Am. J. Cardiol. 61:1988;1106-1107
18. Murgatroyd F.D., Slade A.K., Sopher S.M., et al. Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. J. Am. Coll. Cardiol. 25:1995;1347-1353
19. Keane D. Impact of pulse characteristics on atrial defibrillation energy requirements. Pacing Clin. Electrophysiol. 17:1994;1048-1057
20. Ammer R., Alt E., Ayers G., et al. Pain threshold for low energy intracardiac cardioversion of atrial fibrillation with low or no sedation. Pacing Clin. Electrophysiol. 20:1997;230-236
21. Tomassoni G., Newby K.H., Kearney M.M., et al. Testing different biphasic waveforms and capacitances: effect on atrial defibrillation threshold and pain perception. J. Am. Coll. Cardiol. 28:1996;695-699
22. Harbinson M.T., Allen J.D., Imam Z., et al. Rounded biphasic waveform reduces energy requirements for transvenous catheter cardioversion of atrial fibrillation and flutter. Pacing Clin. Electrophysiol. 20:1997;226-229
23. Kidwai B.J., Allen J.D., Harbinson M.T., et al. Waveform optimization for internal atrial defibrillation: effects of waveform rounding, phase duration, and voltage swing. Pacing Clin. Electrophysiol. 24:2001;1198-1207
24. Mitchell A.R., Spurrell P.A., Kamalvand K., et al. What is the optimal electrode configuration for atrial defibrillators in man? Europace. 4:2002;41-44
25. Timmermans C., Nabar A., Rodriguez L.M., et al. Use of sedation during cardioversion with the implantable atrial defibrillator. Circulation. 100:1999;1499-1501